| Tyyppi : |
Lehti |
| Internet-yhteys : |
10.1371/journal. pone.0164577 |
|
| Tutkimus Joukkueet : |
Montreal - Centre hospitalier Sainte Justine |
| Tekijät : |
Friciu M, Zaraa S, Roullin G, Leclair G. |
| Otsikko : |
Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions. |
| Numero : |
PlosOne 2017 |
|
| Todisteiden määrä : |
|
| Fyysinen vakaus : |
|
| Kemiallinen stabiilisuus : |
|
| Muut menetelmät : |
|
| Commentairesvaleur : |
|
Luettelo yhdisteistä
 Diazoxide
|
 |
 |
 |
 |
500 mg
Proglycem® |
|
23-27°C |
 |
| 90 |
 |
|
|
|
|
 |
500 mg
® = ? |
| Glyseroli |
0.75 mL |
| Oral Mix SF® |
>> 50 mL |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
500 mg
® = ? |
| Glyseroli |
0.75 mL |
| Oral Mix® |
>> 50 mL |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
500 mg
Proglycem® |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
500 mg
® = ? |
| Glyseroli |
0.75 mL |
| Oral Mix® |
>> 50 mL |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
500 mg
® = ? |
| Glyseroli |
0.75 mL |
| Oral Mix SF® |
>> 50 mL |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
500 mg
Proglycem® |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
500 mg
Proglycem® |
|
3-7°C |
|
| 90 |
|
|
|
|
 |
|
10 mg
Proglycem® |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
10 mg
Proglycem® |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
10 mg
® = ? |
| Glyseroli |
0.015 mL |
| Oral Mix® |
>> 1 mL |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
10 mg
® = ? |
| Glyseroli |
0.015 mL |
| Oral Mix SF® |
>> 1 mL |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
10 mg
Proglycem® |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
10 mg
Proglycem® |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
10 mg
® = ? |
| Glyseroli |
0.015 mL |
| Oral Mix® |
>> 1 mL |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
10 mg
® = ? |
| Glyseroli |
0.015 mL |
| Oral Mix SF® |
>> 1 mL |
|
3-7°C |
|
| 90 |
|
|
|
|
|
